Arca
Skip to content
Tools
Tools

Mometasone Furoate Ointment USP

Recall D-1286-2015, part of FDA recall event 71765. See Perrigo Israel Pharmaceuticals's company page.

Perrigo Israel Pharmaceuticals started this Class III drug recall on Jul 13, 2015 (voluntary: firm initiated); FDA lists it as terminated, terminated Feb 11, 2016.

  • Classification: Class III
  • Started: Jul 13, 2015
  • Status: Terminated

Why It Was Recalled

Class III

Subpotent drug

Record

Product
Mometasone Furoate Ointment USP, 0.1%, 15 g tubes, Rx Only, Manufactured by Perrigo, Yeruham 80500, Israel, Distributed by Perrigo, Allegan, MI 49010, NDC 45802-0119-37
Quantity
158,268 tubes
Lots and codes
Lot # 063630, Exp 04/16; 069793, Exp 11/16; 071745, Exp 02/17; 076150, Exp 07/17; 081317, Exp 12/17
Distribution
Nationwide and Puerto Rico
Recalling firm
Perrigo Israel Pharmaceuticals, Yeruham, N/A, Israel
How the firm notified
Letter
FDA classified
Aug 5, 2015

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.